These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
607 related articles for article (PubMed ID: 26175217)
41. MAPK, beta-amyloid and synaptic dysfunction: the role of RAGE. Origlia N; Arancio O; Domenici L; Yan SS Expert Rev Neurother; 2009 Nov; 9(11):1635-45. PubMed ID: 19903023 [TBL] [Abstract][Full Text] [Related]
42. RAGE mediated intracellular Aβ uptake contributes to the breakdown of tight junction in retinal pigment epithelium. Park SW; Kim JH; Park SM; Moon M; Lee KH; Park KH; Park WJ; Kim JH Oncotarget; 2015 Nov; 6(34):35263-73. PubMed ID: 26431165 [TBL] [Abstract][Full Text] [Related]
43. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Yan SD; Chen X; Fu J; Chen M; Zhu H; Roher A; Slattery T; Zhao L; Nagashima M; Morser J; Migheli A; Nawroth P; Stern D; Schmidt AM Nature; 1996 Aug; 382(6593):685-91. PubMed ID: 8751438 [TBL] [Abstract][Full Text] [Related]
44. RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease. Chen X; Walker DG; Schmidt AM; Arancio O; Lue LF; Yan SD Curr Mol Med; 2007 Dec; 7(8):735-42. PubMed ID: 18331231 [TBL] [Abstract][Full Text] [Related]
45. G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer's type patients in Turkish population. Ataç ZS; Alaylıoğlu M; Dursun E; Gezen-Ak D; Yılmazer S; Gürvit H J Clin Neurosci; 2019 Jan; 59():197-201. PubMed ID: 30389362 [TBL] [Abstract][Full Text] [Related]
46. Receptor for advanced glycation end-products in neurodegenerative diseases. Juranek J; Ray R; Banach M; Rai V Rev Neurosci; 2015; 26(6):691-8. PubMed ID: 26226128 [TBL] [Abstract][Full Text] [Related]
47. epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis. Schmitt HP Med Hypotheses; 2006; 66(5):898-906. PubMed ID: 16442744 [TBL] [Abstract][Full Text] [Related]
48. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Deane R; Wu Z; Zlokovic BV Stroke; 2004 Nov; 35(11 Suppl 1):2628-31. PubMed ID: 15459432 [TBL] [Abstract][Full Text] [Related]
49. Role of Blood-Brain Barrier in Alzheimer's Disease. Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323 [TBL] [Abstract][Full Text] [Related]
50. Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of Alzheimer's disease. Hu Q; Yu B; Chen Q; Wang Y; Ling Y; Sun S; Shi Y; Zhou C Mol Med Rep; 2018 Jan; 17(1):827-834. PubMed ID: 29115637 [TBL] [Abstract][Full Text] [Related]
51. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice. Vodopivec I; Galichet A; Knobloch M; Bierhaus A; Heizmann CW; Nitsch RM Neurodegener Dis; 2009; 6(5-6):270-80. PubMed ID: 20145420 [TBL] [Abstract][Full Text] [Related]
52. QKL injection ameliorates Alzheimer's disease-like pathology by regulating expression of RAGE. Dou J; Zhang X; Hu C; Gao Y; Zhao Y; Hei M; Wang Z; Guo N; Zhu H Exp Gerontol; 2024 Jun; 190():112422. PubMed ID: 38599502 [TBL] [Abstract][Full Text] [Related]
53. The novel RAGE interactor PRAK is associated with autophagy signaling in Alzheimer's disease pathogenesis. Kim Y; Kim C; Son SM; Song H; Hong HS; Han SH; Mook-Jung I Mol Neurodegener; 2016 Jan; 11():4. PubMed ID: 26758977 [TBL] [Abstract][Full Text] [Related]
54. RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study. Wang P; Huang R; Lu S; Xia W; Cai R; Sun H; Wang S PLoS One; 2016; 11(1):e0145521. PubMed ID: 26745632 [TBL] [Abstract][Full Text] [Related]